India’s drug price regulator has capped retail prices for 53 drug formulations used in treating various diseases and ...

Guwahati witnessed an influx of half a million devotees for the Ambubachi Mela, providing cover for a group trafficking tiger ...

Seaweed farming also presents a lucrative opportunity for farmers, with potential earnings of up to Rs 13.28 lakh per hectare ...

Aushadhi Diwas shows India’s commitment to provide quality and affordable medicines for all people, said Prime Minister ...

The Indian QR coding programme meant to protect domestic drug supplies has failed, and is now a gift to the counterfeiters.

India's drug regulator aims to implement various reforms, including streamlining export clearances for unapproved drugs and simplifying the manufacturing licensing process, in an effort to reduce the ...

With the government taking several measures to ensure the quality, safety and efficacy of medicines, the Indian ...

Another drug Durvalumab (Imfinzi), used to treat lung cancer, demonstrated robust growth last year. According to a report by HDFC Securities, the oncology market in India is forecast to grow by $ ...

India and New Zealand started discussing a trade agreement called the Comprehensive Economic Cooperation Agreement (CECA) in April 2010. The goal was to make it easier for both countries to trade ...

The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...

Pharma stocks are down, but is this a golden buying opportunity? With India's booming sector and low P/E stocks in focus, discover if these undervalued gems could fuel your next big investment move!

The price of empagliflozin, a commonly prescribed diabetes drug, has been slashed by a staggering 90% in India. This ...